Increasing Mupirocin Resistance of  Staphylococcus Aureus  in CAPD — Should it Continue to be Used as Prophylaxis? | Zendy

Conly John M. | Zendy; Vas Stephen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increasing Mupirocin Resistance of Staphylococcus Aureus in CAPD — Should it Continue to be Used as Prophylaxis?

Author(s) -

Conly John M.,

Vas Stephen

Publication year - 2002

Publication title -

peritoneal dialysis international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.79

H-Index - 83

eISSN - 1718-4304

pISSN - 0896-8608

DOI - 10.1177/089686080202200601

Subject(s) - mupirocin , medicine , staphylococcus aureus , notice , limiting , peritoneal dialysis , methicillin resistant staphylococcus aureus , intensive care medicine , microbiology and biotechnology , bacteria , biology , mechanical engineering , engineering , political science , law , genetics

This editorial summarizes the mechanisms of mupirocin resistance and the conditions that promote its development. While there is increasing evidence that high-level mupirocin resistance is developing during systematic use of mupirocin as prophylaxis against Staphylococcus aureus , the appearance of resistance does not preclude the beneficial effect of regular prophylaxis. Vigilance has to be exercised to notice larger-scale resistance that may require limiting the use of mupirocin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research